Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth E. Sherman, MD, PhD
University of Cincinnati
Study Chair - Raymond Chung, MD
Harvard/Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Aids Clinical Trials Unit Crs
San Juan, Puerto Rico
- Alabama Therapeutics Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- University of Southern California Crs
Los Angeles, California, United States
- Stanford Aids Clinical Trials Unit Crs
Palo Alto, California, United States
- Ucsd Antiviral Research Center Crs
San Diego, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- Santa Clara Valley Med. Ctr.
San Jose, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Georgetown University Crs (gu Crs)
Washington D.C., District of Columbia, United States
- Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana, United States
- Indiana Univ. School of Medicine, Wishard Memorial
Indianapolis, Indiana, United States
- Johns Hopkins University Crs
Baltimore, Maryland, United States
- Beth Israel Deaconess Med. Ctr., Actg Crs
Boston, Massachusetts, United States
- Brigham and Women'S Hosp. Actg Crs
Boston, Massachusetts, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.
Omaha, Nebraska, United States
- Beth Israel Med. Ctr., Actu
New York, New York, United States
- Columbia P&s Crs
New York, New York, United States
- Ny Univ. Hiv/aids Crs
New York, New York, United States
- Weill Cornell Chelsea Crs
New York, New York, United States
- Weill Cornell Uptown Crs
New York, New York, United States
- Mccree Mcculler Wellness Ctr. at the Connection, Infectious Disease Unit
Rochester, New York, United States
- Trillium Health Actg Crs
Rochester, New York, United States
- Univ. of Rochester Actg Crs
Rochester, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Cincinnati Crs
Cincinnati, Ohio, United States
- Metrohealth Crs
Cleveland, Ohio, United States
- Univ. of Pennsylvania Health System, Presbyterian Med. Ctr.
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs
Pittsburgh, Pennsylvania, United States
- the Miriam Hospital Clinical Research Site (tmh Crs) Crs
Providence, Rhode Island, United States
- Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
- Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic
Dallas, Texas, United States
- Univ. of Texas Medical Branch, Actu
Galveston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2004
- Primary completion
- 31 May 2007
- Completion
- 28 Feb 2009
- Last update posted
- 8 Nov 2021
- Registered enrollment
- 333
- Registry id
- NCT00078403
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.